NCT02241772View on ClinicalTrials.gov

A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

February 28, 2015

Conditions
Elevated Lp(a)
Interventions
DRUG

TA-8995

DRUG

Placebo

Trial Locations (1)

DK-2730

Herlev Hospital, Herlev

All Listed Sponsors
lead

Xention Ltd

INDUSTRY

NCT02241772 - A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a) | Biotech Hunter | Biotech Hunter